Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
EVS7-4 Scientific rationale for combination inhalers — Peter J Barnes (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
EVS7-4 Scientific rationale for combination inhalers
Shared by
Peter J Barnes
Imperial College London
EVS7-4 Scientific rationale for combination inhalers
Article
2006
en
Related publications
Editorial Material
2019
Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies
Masatoshi Kudo
Article
2002
Scientific rationale for inhaled combination therapy with long-acting β<sub>2</sub>-agonists and corticosteroids
Peter J Barnes
Authors
Peter J Barnes
Imperial College London
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2007
Scientific rationale for using a single inhaler for asthma control
Peter J Barnes
Article
1996
Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
Sir Nicholas White
,
Piero Olliaro
Parasitology Today
Article
2020
Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.